Gilead Sciences, Inc.GILDNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P31
Within normal range
vs 2Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.04% |
| Q3 2025 | 396.74% |
| Q2 2025 | -52.93% |
| Q1 2025 | -40.94% |
| Q4 2024 | -30.96% |
| Q3 2024 | 225.21% |
| Q2 2024 | -40.29% |
| Q1 2024 | 2.31% |
| Q4 2023 | 23.59% |
| Q3 2023 | -24.94% |
| Q2 2023 | 34.06% |
| Q1 2023 | -32.06% |
| Q4 2022 | -10.34% |
| Q3 2022 | 58.88% |
| Q2 2022 | -2.07% |
| Q1 2022 | -42.59% |
| Q4 2021 | -1.48% |
| Q3 2021 | 40.46% |
| Q2 2021 | -11.26% |
| Q1 2021 | 36.22% |
| Q4 2020 | -14.84% |
| Q3 2020 | -12.31% |
| Q2 2020 | 78.69% |
| Q1 2020 | -44.34% |
| Q4 2019 | -2.46% |
| Q3 2019 | 12.94% |
| Q2 2019 | 48.51% |
| Q1 2019 | -32.75% |
| Q4 2018 | 6.01% |
| Q3 2018 | 40.62% |
| Q2 2018 | -30.70% |
| Q1 2018 | -17.54% |
| Q4 2017 | 2.19% |
| Q3 2017 | -23.60% |
| Q2 2017 | 20.55% |
| Q1 2017 | -16.09% |
| Q4 2016 | -20.65% |
| Q3 2016 | -11.88% |
| Q2 2016 | 20.70% |
| Q1 2016 | -15.26% |